{"id":"https://openalex.org/W55739404","doi":null,"title":"Efficacy of neoadjuvant cisplatin and oral capecitabine in triple-negative breast cancers: a pilot study.","display_name":"Efficacy of neoadjuvant cisplatin and oral capecitabine in triple-negative breast cancers: a pilot study.","publication_year":2013,"publication_date":"2013-05-01","ids":{"openalex":"https://openalex.org/W55739404","mag":"55739404","pmid":"https://pubmed.ncbi.nlm.nih.gov/23880712"},"language":"en","primary_location":{"id":"pmid:23880712","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23880712","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical advances in hematology & oncology : H&O","raw_type":"Clinical Trial, Phase II"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110894404","display_name":"Khurram Bilal Tariq","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]},{"id":"https://openalex.org/I61515104","display_name":"University of Florida Health Science Center","ror":"https://ror.org/0419bgt07","country_code":"US","type":"education","lineage":["https://openalex.org/I61515104"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khurram Tariq","raw_affiliation_strings":["Division of Hematology and Medical Oncology, University of Florida College of Medicine, Jacksonville, FL 32209, USA. Khurram.Tariq@jax.ufl.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, University of Florida College of Medicine, Jacksonville, FL 32209, USA. Khurram.Tariq@jax.ufl.edu","institution_ids":["https://openalex.org/I33213144","https://openalex.org/I61515104"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008407792","display_name":"Fauzia N. Rana","orcid":"https://orcid.org/0000-0002-1010-6541","observed_orcids":["https://orcid.org/0000-0002-1010-6541"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fauzia Rana","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088844915","display_name":"Laila Samiian","orcid":"https://orcid.org/0009-0003-9267-9099","observed_orcids":["https://orcid.org/0009-0003-9267-9099"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laila Samiian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001242443","display_name":"John W. Kilkenny","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John W Kilkenny","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059736605","display_name":"Rubina Khan","orcid":"https://orcid.org/0009-0007-8087-606X","observed_orcids":["https://orcid.org/0009-0007-8087-606X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rubina Khan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110820290","display_name":"Naeem Latif","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naeem Latif","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.00398636,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"11","issue":"5","first_page":"291","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11134","display_name":"Breast Lesions and Carcinomas","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":1.0},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.9900000095367432},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8659999966621399},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.6230000257492065},{"id":"https://openalex.org/keywords/hand-foot-syndrome","display_name":"hand-foot syndrome","score":0.9229999780654907},{"id":"https://openalex.org/keywords/pathological-response","display_name":"pathological response","score":0.8429999947547913},{"id":"https://openalex.org/keywords/african-american-patients","display_name":"African American patients","score":0.7350000143051147}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9491177201271057},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.8117649555206299},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6606600284576416},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.602059543132782},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5923780798912048},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5849138498306274},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.558937668800354},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5386083126068115},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4950236678123474},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.47495388984680176},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4290725886821747},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4289677143096924},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3714209198951721},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2730472683906555},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000069287","descriptor_name":"Capecitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020360","descriptor_name":"Neoadjuvant Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:23880712","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23880712","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical advances in hematology & oncology : H&O","raw_type":"Clinical Trial, Phase II"},{"id":"mag:55739404","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23880712","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W133150085","https://openalex.org/W1523531555","https://openalex.org/W1965966073","https://openalex.org/W1976960697","https://openalex.org/W1992661182","https://openalex.org/W2019267973","https://openalex.org/W2035570331","https://openalex.org/W2051989799","https://openalex.org/W2070086300","https://openalex.org/W2096027508","https://openalex.org/W2101673433","https://openalex.org/W2102596641","https://openalex.org/W2125094267","https://openalex.org/W2127914534","https://openalex.org/W2142486051","https://openalex.org/W2154142993","https://openalex.org/W2157285286","https://openalex.org/W2159238482","https://openalex.org/W2170602872"],"related_works":["https://openalex.org/W2560203905","https://openalex.org/W2554359715","https://openalex.org/W2788295857","https://openalex.org/W2598712213","https://openalex.org/W3216766182","https://openalex.org/W3092178973","https://openalex.org/W2775785454","https://openalex.org/W2889939378","https://openalex.org/W2907672600","https://openalex.org/W2981485737"],"abstract_inverted_index":{"Due":[0],"to":[1,17,135,215,226],"the":[2,62,72,160,172,220,260,269],"lack":[3],"of":[4,64,96,159,245,271],"molecular":[5],"targets,":[6],"triple-negative":[7],"breast":[8,28,150],"cancers":[9,29],"(TNBCs)":[10],"typically":[11],"represent":[12],"a":[13,31,58,156,167],"worse":[14,242],"prognosis":[15],"compared":[16,225],"their":[18],"hormone-positive":[19],"counterparts.":[20],"While":[21],"neoadjuvant":[22,73,221,261],"chemotherapy":[23,38,50,218],"has":[24,43],"been":[25,45],"used":[26],"for":[27,30,40,263],"long":[32],"time,":[33],"there":[34],"is":[35],"no":[36,207],"standard":[37],"regimen":[39,258],"TNBCs.":[41,53,264],"Cisplatin":[42],"generally":[44],"regarded":[46],"as":[47],"an":[48],"effective":[49],"agent":[51],"against":[52],"However,":[54,265],"here":[55],"we":[56,252],"present":[57],"pilot":[59],"study":[60],"involving":[61],"use":[63,270],"cisplatin":[65,230,246,272],"in":[66,71,75,115,187,219,231,259],"combination":[67,217,239,257],"with":[68,78,228,237,273],"oral":[69],"capecitabine":[70],"setting":[74,222,262],"16":[76],"patients":[77,81,87,91,99,105,120,132,144,148,154,162,175,199],"TNBC.":[79],"Twelve":[80],"were":[82,88,133,206],"African":[83],"American":[84],"and":[85,103,118,130,152,171,184,194,197],"4":[86,94,104,209],"white.":[89],"Six":[90],"completed":[92,100,106],"all":[93],"cycles":[95],"chemotherapy,":[97,142],"6":[98],"3":[101,131,181],"cycles,":[102],"2":[107,116,174],"cycles.":[108],"A":[109],"complete":[110,177],"clinical":[111,123],"response":[112,170,214],"was":[113,223,240],"observed":[114],"patients,":[117],"10":[119],"achieved":[121,166],"partial":[122,168],"response.":[124,179],"One":[125],"patient":[126,191],"had":[127,149,155,164,176,200],"progressive":[128],"disease,":[129],"lost":[134],"follow-up":[136],"or":[137,210],"taken":[138],"off":[139],"study.":[140],"Following":[141],"12":[143,161],"underwent":[145],"surgery":[146,165],"(7":[147],"conservation,":[151],"5":[153,198,211],"mastectomy).":[157],"Ten":[158],"who":[163],"pathologic":[169,178],"other":[173,274],"Grade":[180],"nausea,":[182],"vomiting,":[183],"diarrhea":[185],"occurred":[186],"7":[188],"patients;":[189],"1":[190],"experienced":[192],"dehydration":[193],"renal":[195],"failure;":[196],"grade":[201,208],"1/2":[202],"hand-foot":[203],"syndrome.":[204],"There":[205],"toxicities.":[212],"The":[213,234],"cisplatin-capecitabine":[216],"suboptimal":[224],"that":[227,244],"single-agent":[229],"prior":[232],"studies.":[233],"toxicity":[235],"profile":[236],"this":[238,256],"also":[241],"than":[243],"alone.":[247],"Based":[248],"on":[249],"our":[250],"findings,":[251],"do":[253],"not":[254],"recommend":[255],"future":[266],"studies":[267],"analyzing":[268],"combinations":[275],"are":[276],"warranted.":[277]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}